Topline data from phase III study of 5- and 10-day dosing regimens of remdesivir in severe COVID-19 April 30, 2020
Innate's avdoralimab studied in phase II trial for patients with COVID-19 and severe pneumonia April 29, 2020
Human recombinant ACE2 blocks the early stages of SARS-CoV-2 infection in cell and tissue models April 29, 2020
European Commission approves Fetcroja for infections due to aerobic Gram-negative bacteria April 28, 2020
Preliminary findings from phase II portion of U.S. phase II/III trial of Kevzara in COVID-19 April 27, 2020
RSS